Lisätietoja julkaisusta saa klikkaamalla sen numeroa.
For full details, please click the number in front of the publication.
|
1 |
Bauer HCF et al. |
The Scandinavian Sarcoma Group Register 1986-2001.
|
|
2 |
Bendardaf R et al. |
Prognostic and predictive molecular markers in colorectal carcinoma.
|
|
3 |
Bendardaf R et al. |
CD44 variant 6 expression predicts response to treatment in advanced colorectal cancer.
|
|
4 |
Bendardaf R et al. |
Response to chemotherapy (irinotecan plus 5-fluorouracil) in colorectal carcinoma can be predicted by tumour DNA content.
|
|
5 |
Elenius K. |
Täsmäpotilaat täsmälääkkeelle.
|
|
6 |
Elenius V et al. |
Inhibition by the soluble syndecan-1 ectodomains delays wound repair in mice overexpressing syndecan-1.
|
|
7 |
Erjala K et al. |
Concomitant vinorelbine and radiation in head and neck squamous cell carcinoma in vitro.
|
|
8 |
Gridelli C et al. |
Oral vinorelbine given as monotherapy to advanced, elderly NSCLC patients: a multicentre phase II trial.
|
|
9 |
Grönroos T et al. |
Comparison of the biodistribution of two hypoxia markers (18F)FETNIM and (18F)FMISO in an experimental mammary carcinoma .
|
|
10 |
Hernberg MM et al. |
The prognostic role of CD4+ and CD8+ lymphocytes during chemoimmunotherapy in metastatic melanoma.
|
|
11 |
Howell A et al. |
Comparison of fulvestrant versus tamoxifen for the treatment of advanced breast cancer in postmenopausal women previously untreated with endocrine therapy: a multinational, double-blind, randomized trial.
|
|
12 |
Huovinen R. |
Levinneen rintasyövän hormonihoito.
|
|
13 |
Huovinen R, Joensuu H. |
Rintasyöpäleikkauksen jälkeiset liitännäishoidot.
|
|
14 |
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans . |
Tobacco Smoke and Involuntary Smoking.
|
|
15 |
Joensuu H et al. |
Risk for distant recurrence of breast cancer detected by mammography screening or other methods.
|
|
16 |
Jyrkkiö S. |
Eturauhassyövän sädehoito.
|
|
17 |
Kailajärvi MEH et al. |
Serum bone markers in breast cancer patients during 5-fluorouracil, epirubicin and cyclophosphamide (FEC) therapy.
|
|
18 |
Kauhava L et al. |
Lower costs of hospital treatment of breast cancer through a population-based mammography screening programme.
|
|
19 |
Kauhava L et al. |
Mammografiaseulonta alentaa rintasyövän sairaalahoidon kustannuksia.
|
|
20 |
Kilpeläinen M et al. |
Tupakasta vieroitus - osa sairauksien hoitoa. Kahden vuoden seurantatuloksia ryhmäohjauksesta Turun yliopistollisessa keskussairaalassa.
|
|
21 |
Kotilainen P et al. |
Positron emission tomography as an aid in the diagnosis and follow-up of Riedel's thyroiditis.
|
|
22 |
Kouri M et al. |
Undifferentiated sinonasal carcinoma may respond to single-fraction boron neutron capture therapy.
|
|
23 |
Kronqvist P et al. |
Predicting aggressive outcome in T1N0M0 breast cancer.
|
|
24 |
Lehtiö K et al. |
Imaging perfusion and hypoxia with PETto predict radiotherapy response in head-and-neck cancer.
|
|
25 |
Minn H et al. |
Imaging of adrenal incidentalomas with PET using 11C-metomidate and 18F-FDG.
|
|
26 |
Mäenpää HO et al. |
Temozolomide treatment in glioma.
|
|
27 |
Nikkola J. |
Integrins and Matrix Metalloproteinases as Prognostic Factors in Metastatic Melanoma.
|
|
28 |
Nikkola J et al. |
Integrin chains beta-1 and alfa-v as prognostic factors in human metastatic melanoma .
|
|
29 |
Ouwehand AC et al. |
Influence of endogenous mucosal microbiota on the adhesion of probiotic bacteria in vitro.
|
|
30 |
Paija O. |
Koskeeko syöpäpotilaan kipu lääkäriä?
|
|
31 |
Pekkola K et al. |
Permanent in vitro growth is associated with poor prognosis in head and neck cancer.
|
|
32 |
Pyrhönen S. |
Systemic therapy in metastatic renal cell carcinoma.
|
|
33 |
Raitanen M et al. |
Head and neck squamous cell carcinoma cell lines are highly sensitive to the new taxanes, BMS-184476, BMS-188797, in vitro.
|
|
34 |
Salminen E et al. |
Dietary attitudes and changes as well as use of supplements and complementary therapies by Australian and Finnish women following the diagnosis of breast cancer.
|
|
35 |
Salminen E et al. |
Effect of adjuvant androgen deprivation on thyroid function tests in prostate cancer patients.
|
|
36 |
Salminen E et al. |
Unmet needs in information flow between breast cancer patients, their spouses, and physicians.
|
|
37 |
Salminen E et al. |
Eturauhassyövän hormonihoidon käytäntö Suomessa 2003.
|
|
38 |
Salminen EK et al. |
Associations between serum testosterone fall and cognitive function in prostate cancer patients.
|
|
39 |
Salminen EK et al. |
Trends in the use of androgen deprivation in prostate cancer.
|
|
40 |
Sihvo EIT et al. |
Adenocarcinoma of the esophagus and the esophagogastric junction: Positron emission tomography improves staging and prediction of survival in distant but not in locoregional disease.
|
|
41 |
Sutinen E . |
Methodological and Clinical Studies on Positron Emission Tomography (PET) in Oncology. With Special Reference to Radiopharmaceuticals Marking Amino Acid and Phospholipid Metabolism.
|
|
42 |
Sutinen E et al. |
Kinetics of [11C]choline uptake in prostate cancer: a PET study.
|
|
43 |
Tanner M et al. |
Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer.
|
|
44 |
Thomasson M et al. |
ErbB4 is downregulated in renal cell carcinoma.
|
|
45 |
Valavaara R. |
Levinneen rintasyövän sädehoito.
|
|
46 |
Vihinen P, Kähäri V-M. |
Melanoma biomarkers - molecular profiling and its clinical implications.
|
|
47 |
Vihinen P et al. |
Ihomelanooman ennustetekijät ja kehittyvät hoitomahdollisuudet.
|